Sign Up Today and Learn More About Patient 21 Stock
Invest in or calculate the value of your shares in Patient 21 or other pre-IPO companies through EquityZen's platform.
Patient 21 Stock (PATO)
Patient 21 is a healthtech company that aims to empower patients and doctors to make better decisions by leveraging data.
About Patient 21 Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
Patient 21 Press Mentions
Stay in the know about the latest news on Patient 21
Patient Portal Market With 20.1% CAGR, Predicted to Generate USD 21.9 Billion In Revenues By 2033
globenewswire • Jun 04, 2024
HealthSnap Secures $25M to Expand Remote Patient Monitoring and Chronic Care Management Solutions
hitconsultant • May 04, 2024
HealthSnap Closes $25 Million Series B Funding Amidst Continued Triple Digit Growth of Remote Patient Monitoring ...
prnewswire • May 04, 2024
Patient21 Nabs $108M To Expand In-Person Health Care Offerings
news • May 22, 2023
Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany
TechCrunch • May 22, 2023
Join now and verify your accreditation status to gain access to:
- Patient 21 current valuation
- Patient 21 stock price
- Available deals in Patient 21 and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Patient 21 Stock
How to invest in Patient 21 stock?
Accredited investors can buy pre-IPO stock in companies like Patient 21 through EquityZen funds. These investments are made available by existing Patient 21 shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Patient 21 stock?
Shareholders can sell their Patient 21 stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
